Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Carisma Therapeutics Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 84 | 2 | 74 | −8 |
| Shares | 44.4M | 67.8K | 28.5M | −15.9M (−35.8%) |
| Value | $26.4M | $41.0K | $23.1M | −$3.33M (−12.6%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Carisma Therapeutics Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 2,678,849 | $2.17M | 0.00% |
| Ergoteles LLC | 989,600 | $802.0K | 0.02% |
| Privium Fund Management (UK) Ltd | 331,392 | $269.0K | 0.31% |
| Qube Research & Technologies Ltd | 169,834 | $138.0K | 0.00% |
| HRT Financial LP | 160,122 | $129.0K | 0.00% |
| LMR Partners LLP | 95,741 | $78.0K | 0.00% |
| Boothbay Fund Management, LLC | 45,471 | $37.0K | 0.00% |
| Balyasny Asset Management LLC | 33,889 | $27.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 30,086 | $24.0K | 0.00% |
| Diametric Capital, LP | 20,532 | $17.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 18,465 | $15.0K | 0.00% |
| Wolverine Trading, LLC | 16,753 | $13.0K | 0.00% |
| StoneX Group Inc. | 14,900 | $12.1K | 0.00% |
| Prelude Capital Management, LLC | 10,639 | $9.00K | 0.00% |
| Credit Suisse AG | 8 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 150 | $0 | 0.00% |
Sold out (24)
Institutions that held Carisma Therapeutics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Price T Rowe Associates Inc | 214,506 | $129.0K |
| Alliancebernstein L.P. | 154,300 | $93.0K |
| Rhumbline Advisers | 149,600 | $90.0K |
| Deutsche Bank AG | 114,309 | $69.0K |
| Citadel Advisors LLC | 110,389 | $67.0K |
| American International Group, Inc. | 99,947 | $60.0K |
| STRS Ohio | 95,900 | $57.0K |
| California State Teachers Retirement System | 87,634 | $53.0K |
| State Board of Administration of Florida Retirement System | 86,564 | $52.0K |
| Voya Investment Management LLC | 83,560 | $50.0K |
| Los Angeles Capital Management LLC | 72,662 | $44.0K |
| Invesco Ltd. | 71,802 | $43.0K |
| First Manhattan Co | 62,000 | $37.0K |
| Principal Financial Group Inc | 59,249 | $35.0K |
| Allspring Global Investments Holdings, LLC | 50,012 | $30.0K |
| Amalgamated Bank | 32,774 | $20.0K |
| Barclays PLC | 32,680 | $19.0K |
| Legal & General Group Plc | 25,896 | $15.0K |
| Meeder Asset Management Inc | 18,228 | $12.0K |
| Ameritas Investment Partners, Inc. | 13,404 | $8.00K |
| Mackenzie Financial Corp | 10,786 | $7.00K |
| Prudential Financial Inc | 11,680 | $7.00K |
| TCI Wealth Advisors, Inc. | 600 | $0 |
| Nuveen Asset Management, LLC | 526,431 | – |
Not filed for Q2 2022 yet (2)
Institutions that held Carisma Therapeutics Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 34,977 | $21.0K |
| Amalgamated Financial Corp. | 32,774 | $20.0K |